Helping employers reclaim control over pharmacy spend: Our investment in RxSaveCard

Prescription drug pricing has become one of the most complex systems in healthcare, shaped by decades of layered incentives that make it nearly impossible to know what a drug really costs. The result is a system that even experienced benefit teams struggle to navigate; one where the same medication can be overpriced in one channel and deeply discounted in another. Employers are increasingly asking a simple question: shouldn’t there be a clearer way to pay for prescriptions?

The pressure to fix prescription pricing is no longer theoretical. Recent FTC reports have shone a spotlight on the problem. And ERISA fiduciary lawsuits have made it clear that employers can be held responsible for overpaying when lower-cost options exist, raising the bar for how pharmacy benefits are managed.

At the same time, GLP-1 medications have become both a breakthrough and a budget shock, often excluded from coverage despite lower prices now available through cash-pay and manufacturer-direct channels. Affordable options exist, but the system isn’t built for employers and their employees to reach them.

Enter RxSaveCard, which gives employers a simple way to access lower drug prices without changing their pharmacy benefits manager (PBM). The platform connects employees to “cash” pricing through retail pharmacies, transparent pharmacies like Cost Plus Drugs, and manufacturer-direct programs like Lilly Direct, allowing employers to subsidize prescriptions at the point of sale and only pay when the card is used.

Behind that simplicity sits a complex web of pharmacy networks, compliance requirements, and payment flows—nuanced work that requires an experienced approach from a standout leadership team. Chris Crawford, a veteran of pharmacy benefit strategy and employer distribution, and Jace Mouse, an experienced builder of card-linked and benefits technology, are translating a complicated system into something employers can actually use.

We are proud to announce that Rock Health Capital co-led RxSaveCard’s $3.3M Seed round alongside Distributed Ventures. RxSaveCard reflects what we look for in early-stage innovation: simple, incentive-aligned, and built by leaders who understand the system from the inside out. We’re thrilled to partner with Chris, Jace, and the RxSaveCard team as they help employers reclaim control over pharmacy spend and bring transparency to prescription pricing.

Learn more about how RxSaveCard helps employers and employees access lower-cost prescriptions, or book a demo here.

Rock Health Capital is an early-stage venture fund focused on digital health. We would love to hear from you. Get in touch!